Vol 9, No 4 (2020)
Letter to the Editor
Published online: 2020-05-22

open access

Page views 702
Article views/downloads 614
Get Citation

Connect on Social Media

Connect on Social Media

Inconsistency amongst the diagnostic criteria based on Ewing’s tests for diagnosing cardiac autonomic neuropathy in diabetes mellitus: an under-rated issue

Pooja Bhati1, M. Ejaz Hussain1
Clin Diabetol 2020;9(4):269-270.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Balcıoğlu AS, Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015; 6(1): 80–91.
  2. Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes. 2018; 9(1): 1–24.
  3. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991; 79(290): 495–502.
  4. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004; 27(12): 2942–2947.
  5. Ewing DJ, Martyn CN, Young RJ, et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985; 8(5): 491–498.
  6. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010; 33(2): 434–441.
  7. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26(5): 1553–1579.
  8. Witte DR, Tesfaye S, Chaturvedi N, et al. EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005; 48(1): 164–171.
  9. Spallone V, Bernardi L, Ricordi L, et al. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes. 1993; 42(12): 1745–1752.
  10. Bellavere F, Bosello G, Fedele D, et al. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1983; 287(6384): 61.
  11. Spallone V, Ziegler D, Freeman R, et al. Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27(7): 639–653.
  12. Mendivil CO, Kattah W, Orduz A, et al. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications. 2016; 30(1): 93–98.
  13. Kempler P, Tesfaye S, Chaturvedi N, et al. EURODIAB IDDM Complications Study Group. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002; 19(11): 900–909.